We hypothesized that the higher glutaminase activity of PegC compared to E. coli-derived asparaginases may be advantageous as it was recently reported that the anti-tumor activity of asparaginases in PDAC is dependent on its glutaminase activity [14]. The gene discussed is ASPG; the disease is neoplasm.